The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy.

Dabravolski SA, Sukhorukov VN, Kalmykov VA, Grechko AV, Shakhpazyan NK, Orekhov AN

Open source

DOI
10.3390/biomedicines10020254
Published
2022 Jan 24
Container
Biomedicines
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/biomedicines10020254,
  title = {The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy.},
  author = {Dabravolski SA and Sukhorukov VN and Kalmykov VA and Grechko AV and Shakhpazyan NK and Orekhov AN},
  year = {2022},
  journal = {Biomedicines},
  doi = {10.3390/biomedicines10020254},
  url = {https://doi.org/10.3390/biomedicines10020254}
}

RIS

TY  - JOUR
TI  - The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy.
AU  - Dabravolski SA
AU  - Sukhorukov VN
AU  - Kalmykov VA
AU  - Grechko AV
AU  - Shakhpazyan NK
AU  - Orekhov AN
PY  - 2022
JO  - Biomedicines
DO  - 10.3390/biomedicines10020254
UR  - https://doi.org/10.3390/biomedicines10020254
ER  - 

APA

SA, D., VN, S., VA, K., AV, G., NK, S., & AN, O. (2022). The Role of KLF2 in the Regulation of Atherosclerosis Development and Potential Use of KLF2-Targeted Therapy.. Biomedicines. https://doi.org/10.3390/biomedicines10020254

Source records